| scholarly article | Q13442814 |
| P50 | author | Franck Dequiedt | Q39200814 |
| P2093 | author name string | Jan Sedlak | |
| Olga Krizanova | |||
| Silvia Pastorekova | |||
| Sona Hudecova | |||
| Martina Takacova | |||
| Maria Bartosova | |||
| Luba Hunakova | |||
| Monika Barathova | |||
| Veronika Simko | |||
| Michal Pastorek | |||
| Olga Sedlakova | |||
| P2860 | cites work | Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy | Q28202355 |
| Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene | Q83353256 | ||
| Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival | Q84380481 | ||
| Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment | Q28247998 | ||
| Exploiting tumour hypoxia in cancer treatment | Q28264146 | ||
| Hypoxia-inducible expression of tumor-associated carbonic anhydrases | Q28647603 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway | Q29617805 | ||
| Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells | Q33728766 | ||
| Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. | Q33945427 | ||
| Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer | Q34139499 | ||
| Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression | Q34192789 | ||
| The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells | Q34285178 | ||
| Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning | Q34610733 | ||
| Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines | Q34911416 | ||
| Reciprocal influence of the p53 and the hypoxic pathways | Q35065006 | ||
| Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma | Q35143496 | ||
| Sulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent | Q35956502 | ||
| Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy | Q36220497 | ||
| Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers | Q36518752 | ||
| Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane | Q36557973 | ||
| DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. | Q36732878 | ||
| Hypoxia and adaptive landscapes in the evolution of carcinogenesis | Q36778738 | ||
| Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells | Q36975191 | ||
| Generating specificity and diversity in the transcriptional response to hypoxia | Q37626406 | ||
| Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways | Q37861928 | ||
| Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors | Q38177264 | ||
| Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice | Q38268094 | ||
| Sulforaphane blocks hypoxia-mediated resistance to TRAIL-induced tumor cell death | Q38475327 | ||
| Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species | Q39143886 | ||
| Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma | Q39197614 | ||
| Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells. | Q39246943 | ||
| Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells | Q39341072 | ||
| Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors. | Q39450874 | ||
| Activation of several concurrent proapoptic pathways by sulforaphane in human colon cancer cells SW620. | Q39831526 | ||
| Role of aryl hydrocarbon receptor in modulation of the expression of the hypoxia marker carbonic anhydrase IX. | Q39893439 | ||
| Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells | Q39971360 | ||
| Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane | Q40023339 | ||
| Hypoxia contributes to development of recurrent endometrial carcinoma. | Q40159415 | ||
| Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. | Q40302650 | ||
| Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate. | Q40351970 | ||
| Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. | Q40489574 | ||
| Cell surface phenotype and increased penetration of human multidrug-resistant ovarian carcinoma cells into in vitro collagen-fibroblasts matrix | Q41243719 | ||
| Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane | Q41610999 | ||
| Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation | Q41646529 | ||
| Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. | Q42538234 | ||
| c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia | Q45190273 | ||
| A microenvironmental model of carcinogenesis. | Q53326346 | ||
| Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer. | Q54533143 | ||
| The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. | Q54577544 | ||
| Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. | Q54585085 | ||
| Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death | Q61908025 | ||
| Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. Identification and characterization of a proximal silencer element | Q73157272 | ||
| VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer | Q79366831 | ||
| Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours | Q79428232 | ||
| P433 | issue | 1 | |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 51-60 | |
| P577 | publication date | 2015-05-05 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy | |
| P478 | volume | 47 |
| Q55492494 | Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway. |
| Q90662863 | Brassicaceae-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer |
| Q33914234 | Combination therapy in combating cancer |
| Q93018164 | Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane |
| Q38794896 | Hypoxic conditions increases H₂S-induced ER stress in A2870 cells. |
| Q95270493 | Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects |
| Q59807366 | Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment |
| Q35973580 | Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells |
| Q37709114 | Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro |
| Q58579152 | The Chemoprevention of Ovarian Cancer: the Need and the Options |
Search more.